Morgan Stanley Maintains Overweight on IDEXX Laboratories, Raises Price Target to $810

Benzinga · 6d ago
Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $805 to $810.